Please login to the form below

Not currently logged in
Email:
Password:

Dayvigo

This page shows the latest Dayvigo news and features for those working in and with pharma, biotech and healthcare.

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Since then, it’s been joined on the market by Eisai’s recently-approved Dayvigo (lemborexant), which is also being tested in Alzheimer’s-relate sleep disturbances and reported positive results

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....